TrialEndocrine-related cancer2023

A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.

Sonia M Abuzakhm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.